TECH
Bio-Techne CorpNASDAQ
Healthcare • Biotechnology
Factor tilt: Large-Cap Blend
$72.78+0.17%
Close Nov 6, 2026
- Market cap
- $11.4B
- 1 month
- +0.5%
- 3 months
- +0.9%
- 1 year
- +21.4%
- 52-week range
- $43.30$72.78
- Dividend, last 12 mo
- $0.32 · 0.44% yield
- Last ex-date
- Aug 24, 2026 · $0.08
- Next-quarter EPS estimate
- $0.45Quarter to Sep 30, 2026 · 7 analysts · revenue $292.2M · -0.3% in 30d
- Short interest
- 4.8% of float7.6M shares · settled Oct 15, 2026 · +2.3% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $1.22B
- Net income
- $181.86M
- Free cash flow
- $263.22M
- Book value
- $2.11B
- Total debt
- $289.09M
- P/E
- 62.7×
- Price / sales
- 9.4×
- Price / book
- 5.4×
- FCF yield
- +2.3%
- Net margin
- +15.0%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Bio-Techne Corp
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.
Read more
The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
- Website
- bio-techne.com
- Headquarters
- Minneapolis, MN, United States
- Employees
- 3,000
- Listed
- Feb 9, 1989
- Fiscal year ends
- June
Company profile from EODHD, stored Nov 6, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 24, 2026 | $321.2M | +1.3% | 65.8% | $74.3M | $54.6M |
| Mar 2026filed May 6, 2026 | $311.4M | -1.5% | 66.9% | $75.5M | $51.1M |
| Dec 2025filed Feb 4, 2026 | $295.9M | -0.4% | 64.6% | $54.5M | $38.0M |
| Sep 2025filed Nov 5, 2025 | $286.6M | -1.0% | 65.6% | $47.7M | $38.2M |
| Jun 2025filed Aug 22, 2025 | $317.0M | +3.5% | 62.7% | -$23.9M | -$17.7M |
| Mar 2025filed May 8, 2025 | $316.2M | +4.2% | 67.9% | $38.7M | $22.6M |
| Dec 2024filed Feb 6, 2025 | $297.0M | +9.0% | 65.3% | $47.4M | $34.9M |
| Sep 2024filed Nov 5, 2024 | $289.5M | +4.5% | 63.2% | $40.0M | $33.6M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 24, 2026 | $1.2B | -0.4% | 65.8% | $251.9M | $181.9M |
| Jun 2025filed Aug 22, 2025 | $1.2B | +5.2% | 64.8% | $102.3M | $73.4M |
| Jun 2024filed Aug 22, 2024 | $1.2B | +2.0% | 66.4% | $206.7M | $168.1M |
| Jun 2023filed Aug 23, 2023 | $1.1B | +2.8% | 67.7% | $298.9M | $285.3M |
| Jun 2022filed Aug 24, 2022 | $1.1B | +18.7% | 68.4% | $296.6M | $272.1M |
| Jun 2021filed Aug 25, 2021 | $931.0M | +26.0% | 68.0% | $237.3M | $140.4M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched TECH. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
7,552,208 shares short
+167,174 shares (+2.3%) vs Sep 30, 2026
4.8% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
7,385,034 shares short
+757,411 shares (+11.4%) vs Sep 15, 2026
4.7% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
6,627,623 shares short
+737,747 shares (+12.5%) vs Aug 31, 2026
4.3% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
5,889,876 shares short
-573,451 shares (-8.9%) vs Aug 14, 2026
3.8% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
6,463,327 shares short
-2,814,015 shares (-30.3%) vs Jul 31, 2026
4.2% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
9,277,342 shares short
-2,846,106 shares (-23.5%) vs Jul 15, 2026
6% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind TECH’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
USD 0.08 per share
Ex-dividend date: Nov 13, 2026 (future recorded date)
Recorded pay date: Nov 23, 2026 (pending)
Cash dividend · Polygon event record
USD 0.08 per share
Ex-dividend date: Aug 24, 2026
Recorded pay date: Sep 4, 2026 (past date)
Cash dividend · Polygon event record
USD 0.08 per share
Ex-dividend date: May 18, 2026
Recorded pay date: May 29, 2026 (past date)
Cash dividend · Polygon event record
USD 0.08 per share
Ex-dividend date: Feb 13, 2026
Recorded pay date: Feb 27, 2026 (past date)
Cash dividend · Polygon event record
USD 0.08 per share
Ex-dividend date: Nov 17, 2025
Recorded pay date: Nov 28, 2025 (past date)
Cash dividend · Polygon event record
USD 0.08 per share
Ex-dividend date: Aug 18, 2025
Recorded pay date: Aug 29, 2025 (past date)
Cash dividend · Polygon event record
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
4 for 1 · forward split
Effective Nov 30, 2022
Each 1 pre-split share becomes 4 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Dec 4, 2000
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Nov 18, 1997
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if TECH is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
67 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Oct 30, 2026
Smart-money 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 4
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
601 filers reported a long position in TECH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
45.9%
of the 175.3M shares 13-F filers reported
Moves vs Q1 2026
8 added1 trimmed
1 new
Net shares held
+17%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $990.9M · 14M shares | 14M | +14.4% |
| 2 | FMR LLC | $904M · 12.8M shares | 12.8M | +62% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $721.9M · 10.2M shares | 10.2M | +0.4% |
| 4 | GOLDMAN SACHS GROUP INC | $518.8M · 7.3M shares | 7.3M | +277.8% |
| 5 | HBK INVESTMENTS L P | $482.2M · 6.8M shares | 6.8M | New |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | $459.7M · 6.5M shares | 6.5M | +0.4% |
| 7 | MORGAN STANLEY | $450.4M · 6.4M shares | 6.4M | -25.3% |
| 8 | STATE STREET CORP | $422.5M · 6M shares | 6M | +1.9% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $377.5M · 5.4M shares | 5.4M | +4.7% |
| 10 | Invesco Ltd. | $352.3M · 5M shares | 5M | +8.7% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of TECH file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 5, 2026 | FMR LLC13G · passive · amended | 0.7%under 5% |
| Apr 29, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive | 7.38% |
| Mar 26, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for TECH
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.